Edition:
United States

IRIDEX Corp (IRIX.A)

IRIX.A on American Stock Exchange

7.20USD
20 Jul 2018
Change (% chg)

$0.25 (+3.60%)
Prev Close
$6.95
Open
--
Day's High
$7.20
Day's Low
$7.20
Volume
0
Avg. Vol
0
52-wk High
$10.13
52-wk Low
$5.33

Chart for

About

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumenta... (more)

Overall

Beta: 1.43
Market Cap(Mil.): $80.42
Shares Outstanding(Mil.): 11.64
Dividend: --
Yield (%): --

Financials

  IRIX.A Industry Sector
P/E (TTM): -- 37.52 33.34
EPS (TTM): -1.26 -- --
ROI: -42.82 8.76 13.18
ROE: -43.53 12.58 15.09

BRIEF-Iridex Corp Q1 Revenue $9.5 Million

* REITERATED ITS GUIDANCE FOR 2018 OF G6 PROBE SHIPMENTS OF 40,000 TO 45,000,

May 03 2018

BRIEF-Iridex Announces Availability Of G-Probe Illuminate Device In Europe

* IRIDEX CORP - AVAILABILITY OF G-PROBE ILLUMINATE DEVICE IN EUROPE Source text for Eikon: Further company coverage:

Mar 20 2018

BRIEF-Iridex Qtrly Loss Per Share $0.44

* IRIDEX ANNOUNCES 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

Mar 08 2018

BRIEF-Iridex Issues Voluntary Recall Of Trufocus Lio Premiere Laser Indirect Ophthalmoscope

* IRIDEX ISSUES VOLUNTARY RECALL OF TRUFOCUS LIO PREMIERE™ LASER INDIRECT OPHTHALMOSCOPE

Feb 23 2018

Earnings vs. Estimates